01-671-904
Chlamydia trachomatis LPS Monoclonal Antibody (CL13-256.2.1), Invitrogen™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 01-671-904-Each-of-1 | In Stock | ₹ 50,507.50 |
01-671-904 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 50,507.50
GST (18%): ₹ 9,091.35
Total Price: ₹ 59,598.85
Antigen
Chlamydia trachomatis LPS
Classification
Monoclonal
Concentration
2 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Bacteria
Product Type
Antibody
Isotype
IgM
Applications
ELISA
Clone
CL13-256.2.1
Conjugate
Unconjugated
Gene Alias
C. trachomatis Lipopolysaccharide; Chlamydia trachomatis Lipopolysaccharide
Immunogen
C. trachomatis elementary bodies.
Quantity
500 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Related Products
Description
- MA1-10673 detects Chlamydia trachomatis LPS from C
- trachomatis serovars A, B, Ba, C, D, E, F, G, H, I, J, K, L1, L2, and L3 samples
- MA1-10673 has been successfully used in ELISA applications
- The MA1-10673 immunogen is C
- trachomatis elementary bodies
- Chlamydia trachomatis is an intracellular organism
- Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men
- Chlamydial infections are believed to be one of the most common of all STDs
- It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year
- Thus, there are many undiagnosed cases of chlamydia in the community
- It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5% to 10%
- Chlamydia is one of the leading causes of blindness in underdeveloped countries.